Research Findings on Nine GlaxoSmithKline Cancer Compounds to be Presented at ASCO 2009
GlaxoSmithKline (GSK) Oncology announced that new clinical data from nine of its oncology molecules will be featured in various presentations at the annual meeting of the American Society of Clinical Oncology (ASCO) in Orlando beginning May 29. The presentations cover GSK Oncology research in solid and blood tumor treatment, supportive care and prevention in an array of difficult to treat tumors including kidney cancer, advanced breast cancer, leukemia and prostate cancer.
Video: Research in Women's Cancers Leading the Personalized Medicine Revolution
Ovarian cancer remains very difficult to detect, and has the highest
recurrence rate of women's cancers
-- Breast cancer is the 2nd leading cause of cancer deaths among women
-- Lifestyle changes and vaccination are two of the strongest methods to
prevent the development of cervical cancer
-- Knowing your family history is still one of the most effective ways to
assess your risk for breast and ovarian cancer
'Cancer from A to Z': A Dictionary of Cancer-Related Terms
Osteosarcoma is the most common and potentially most dangerous bone cancer. It primarily affects young people between the ages of 10 - 25. In "Cancer from A to Z" (published by AuthorHouse), a new cancer dictionary by Dr. Edward Laughlin, learn that before the 1980's the only treatment for osteosarcoma was amputation.
Related Searches
| Related News: |
